Table 2.
Participant characteristics.
| Characteristics | Values | |||
| Demographics | ||||
|
|
Age (years), mean (SD) | 63.07 (8.66) | ||
|
|
Non-Hispanic White, n (%) | 13 (93) | ||
|
|
Bachelor’s degree, n (%) | 8 (57) | ||
|
|
Income >US $40,000 per year, n (%) | 8 (57) | ||
|
|
Employed full-time, n (%) | 8 (57) | ||
|
|
Married, n (%) | 12 (86) | ||
|
|
Comorbiditiesa, mean (SD) | 2.38 (2.10) | ||
|
|
β-Blocker medication use, n (%) | 0 (0) | ||
|
|
Antihypertensive medication use, n (%) | 1 (7) | ||
|
|
Diagnosed with depression, n (%) | 4 (29) | ||
|
|
Diagnosed with anxiety, n (%) | 4 (29) | ||
|
|
BMI (kg/m2), mean (SD) | 29.14 (4.71) | ||
| Clinical features | ||||
|
|
Cancer stage, n (%) | |||
|
|
|
I | 12 (86) | |
|
|
|
II | 2 (14) | |
|
|
Time since diagnosis (months), mean (SD) | 16.57 (7.97) | ||
|
|
Chemotherapy, n (%) | 3 (21) | ||
|
|
Radiation, n (%) | 9 (64) | ||
|
|
Hormonal therapy, n (%) | 9 (64) | ||
|
|
Months of hormonal therapy, mean (SD) | 13.44 (5.64) | ||
aComorbid conditions include diagnosed arthritis, osteoporosis, asthma, chronic obstructive pulmonary disease, angina, heart failure, previous myocardial infarction, vascular disease, diabetes, tremors, gastrointestinal disease, visual impairment, hearing impairment, degenerative disk disease, anxiety, and depression.